Bexarotene

FDA Approved: * August 12, 2014
Pharm Company: * BANNER PHARMACAPS
Category: Cancer

Bexarotene, sold under the brand Targretin, is an antineoplastic (anti-cancer) agent approved by the U.S. Food and Drug Administration (FDA) (December 1999) and the European Medicines Agency (EMA) (March 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).[1] It is a third-generation retinoid.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism 6 Physical properties 7 History 8 References Medical uses... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Bexarotene 75 mg Oral Capsule, Liquid Filled
NDC: 0054-0399
Labeler:
Hikma Pharmaceuticals USA Inc.
Bexarotene 75 mg Oral Capsule, Liquid Filled
NDC: 0378-6955
Labeler:
Mylan Pharmaceuticals Inc.
Bexarotene 75 mg Oral Capsule, Liquid Filled
NDC: 0591-2832
Labeler:
Actavis Pharma, Inc.
Bexarotene 75 mg Oral Capsule
NDC: 0832-0285
Labeler:
Upsher-smith Laboratories, Inc.
Bexarotene 75 mg Oral Capsule
NDC: 42291-072
Labeler:
Avkare
Bexarotene 75 mg Oral Capsule, Liquid Filled
NDC: 42292-007
Labeler:
Mylan Institutional Inc.
Bexarotene 75 mg Oral Capsule, Liquid Filled
NDC: 43975-315
Labeler:
Amerigen Pharmaceuticals Inc.
Bexarotene 1 g/100g Topical Gel
NDC: 68682-002
Labeler:
Oceanside Pharmaceuticals
Bexarotene 75 mg Oral Capsule, Liquid Filled
NDC: 68682-003
Labeler:
Oceanside Pharmaceuticals
Bexarotene 75 mg Oral Capsule
NDC: 69238-1250
Labeler:
Amneal Pharmaceuticals LLC
More Results

Related Brands

Drugs with the same active ingredients

Popular Topics

Bexarotene for Alzheimer's

Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently...

4 REPLIES